Department of Organic Chemistry, Chemical Diversity Research Institute, 114401 Khimki, Moscow Region, Russia.
J Med Chem. 2011 Dec 8;54(23):8161-73. doi: 10.1021/jm201079g. Epub 2011 Nov 10.
Syntheses, biological evaluation as 5-HT(6) receptor (5-HT(6)R) antagonists, and structure-activity relationships for a series of novel 5,7-disubstituted (3-arylsulfonyl-pyrazolo[1,5-a]pyrimidins are disclosed. The molecule conformational flexibility in the series is restricted by formation of the intramolecular hydrogen bond between 3-sulfo and 2-methylamino groups, which renders high potency and high selectivity to block serotonin-induced responses in HEK-293 cells stably expressing human 5-HT(6)R. In this work, we tested the hypothesis if addition of a positively ionizable group (PI) to the pyrimidine ring of the scaffold members in positions 5, 6, or 7 could further increase their 5HT(6)R blocking potency. We show that the presence of the PI group with small substituents does not substantially affect either potency or selectivity of the ligands while causing substantial changes in their cLogP values. This provides a possibility for designing of the 5HT(6)R ligands with modified ADME characteristics without grossly affecting efficiency of their interaction with the receptor. In respect to the structure-activity relationship (SAR), among other physiochemical parameters, only the molecule size and shape (described by gyration radii) showed a clear tendency for more compact molecules to be more potent antagonists of this receptor.
本研究合成了一系列新型 5,7-取代(3-芳磺酰基-吡唑并[1,5-a]嘧啶),并对其作为 5-羟色胺 6 型受体(5-HT6R)拮抗剂的生物评价和构效关系进行了研究。该系列化合物分子构象的灵活性受到 3-磺酰基和 2-甲氨基之间形成的分子内氢键的限制,这使得它们对稳定表达人 5-HT6R 的 HEK-293 细胞中 5-羟色胺诱导的反应具有高活性和高选择性。在本工作中,我们测试了一个假设,如果在嘧啶环的 5、6 或 7 位上引入可电离正电荷基团(PI),是否可以进一步提高其对 5-HT6R 的阻断活性。结果表明,在配体中引入小取代基的 PI 基团不会显著影响其活性或选择性,而会导致其 cLogP 值发生显著变化。这为设计具有改良 ADME 特性的 5-HT6R 配体提供了可能,而不会对其与受体的相互作用效率产生重大影响。就构效关系(SAR)而言,在其他物理化学参数中,只有分子大小和形状(由回转半径描述)显示出更紧凑的分子具有更高的活性的明显趋势。